Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
2
pubmed:dateCreated
2008-1-24
pubmed:abstractText
In pediatric meningococcal sepsis, an imbalance between coagulation and fibrinolysis and proinflammatory action play major roles. We hypothesized that thrombin activatable fibrinolysis inhibitor (TAFI) and/or TAFI activation markers are involved in the pathogenesis of meningococcal sepsis.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Feb
pubmed:issn
1538-7836
pubmed:author
pubmed:issnType
Electronic
pubmed:volume
6
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
268-76
pubmed:meshHeading
pubmed-meshheading:18021301-Adolescent, pubmed-meshheading:18021301-Carboxypeptidase U, pubmed-meshheading:18021301-Child, pubmed-meshheading:18021301-Child, Preschool, pubmed-meshheading:18021301-Disseminated Intravascular Coagulation, pubmed-meshheading:18021301-Enzyme Activation, pubmed-meshheading:18021301-Female, pubmed-meshheading:18021301-Genetic Predisposition to Disease, pubmed-meshheading:18021301-Genotype, pubmed-meshheading:18021301-Humans, pubmed-meshheading:18021301-Infant, pubmed-meshheading:18021301-Male, pubmed-meshheading:18021301-Meningococcal Infections, pubmed-meshheading:18021301-Mutation, Missense, pubmed-meshheading:18021301-Neisseria meningitidis, pubmed-meshheading:18021301-Point Mutation, pubmed-meshheading:18021301-Serotyping, pubmed-meshheading:18021301-Severity of Illness Index, pubmed-meshheading:18021301-Shock, Septic, pubmed-meshheading:18021301-Survival Analysis, pubmed-meshheading:18021301-Treatment Outcome
pubmed:year
2008
pubmed:articleTitle
Thrombin-activatable fibrinolysis inhibitor is associated with severity and outcome of severe meningococcal infection in children.
pubmed:affiliation
Department of Pediatrics, Erasmus MC-Sophia, Rotterdam, The Netherlands.
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't